A review on upper respiratory tract infection

  • K. Vijaya Sree Pharm D, V Year Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh.
  • K. Saranya Pharm D, V Year Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh.
  • JK. Vandana singh Pharm D, V Year Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh
  • P. Narayana Swamy Associate professor, Department of Pharmacy Practice, Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh.
    swamy.cool99@gmail.com
  • Y.Ramesh Professor and Head, Department of Pharmacy Practice, Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh.
  • Y. Prapurna Chandra Principal of Ratnam Institute of Pharmacy, spsr Nellore, Andhra Pradesh.

Abstract

Upper respiratory tract infection (URI) is a general term for a heterogeneous group of illnesses caused by numerous etiologic agents that affect the mucosal lining of the upper respiratory tract, including the middle-ear cavity and par nasal sinuses. URIs are primarily caused by viruses, rhinoviruses being the most common etiological agents. Respiratory viruses transmit easily via direct contact or aerosols. The incidence of URI is highest in children who suffer 6–8 infections per year. The main symptoms of URI are nasal blockage and discharge, sneezing, sore throat, and cough. Fever occurs variably, most commonly in children. Viral URIs often predispose to bacterial complications. Acute otitis media is the most common complication in children, whereas sinusitis and pneumonia are more frequent in adults and the elderly. The treatment of URI is mainly symptomatic because specific antiviral are available only for influenza viruses. Antibiotics have no efficacy for viral URI but are commonly used for treating acute otitis media and sinusitis. Most URIs are self-limited illnesses with an average duration of 7–10 days and an excellent prognosis.

Keywords: Upper respiratory tract infection, par nasal sinuses, antiviral, influenza viruses

Downloads

Download data is not yet available.

References

1. Cherry JD (1998) The common cold. In: Feigin RD and Cherry JD (eds.) Textbook of Pediatric Infectious Diseases, 4th edn., pp. 128–133. Philadelphia: Saunders.
2. Heikkinen T and Chonmaitree T (2003) Importance of respiratory viruses in acute otitis media. Clinical Microbiology Reviews 16: 230–241.
3. Heikkinen T and Ja¨ rvinen A (2003) The common cold. Lancet 361: 51–59.
4. Ison MG, Johnston SL, Openshaw P, Murphy B, and Hayden F (2004) Current research on respiratory viral infections: Fifth International Symposium. Antiviral Research 62: 75–110.
5. Ruuskanen O and Hyypia¨ T (2005) Rhinovirus: is it really a relevant pathogen? In: Kimpen J and Ramilo O (eds.) The Microbe–Host Interface in Respiratory Tract Infections, pp. 291–317. Norfolk: Horizon Bioscience.
6. Treanor JJ (2002) Respiratory infections. In: Richman DD, Whitley RJ, and Hayden FG (eds.) Clinical Virology, 2nd edn.,pp. 7–26. Washington, DC: ASM Press.
7. Baines PB and Sarginson RE (2004) Upper airway obstruction. Hospital Medicine 65(2): 108–111.
8. Cummings CW, Fredrickson JM, Harker LA, Krause CJ and Schuller DE (1986) Otolaryngology – Head and Neck Surgery, vol. 3, pp. 1895–1918. St Louis, MO: Mosby.
9. Hammer J (2004) Acquired upper airway obstruction. Paediatric Respiratory Reviews 5(1): 25–33.
10. Jafek BW and Stark AK (1996) ENT Secrets, Upper Air Obstruc- tion, pp. 296–302. Philadelphia: Hanley & Belfus. Kerr AG (1997) Scott–Brown’s Otolaryngology, 6th edn., vol. 6. London: Arnold.
11. Kimmelman CP (1989) Nasal obstruction due to benign and ma- lignant neoplasms. Otolaryngologic Clinics of North America 22(2): 351–366.
12. Kimmelman CP (1989) Rhinitis and nasal obstruction. Otolaryngologic Clinics of North America 22(2): 307–318.
13. Roland NJ, McRae RDR, and McCombe AW (2001) Choanal atresia; epiglottitis. In: Key Topics in Otolaryngology and Head and Neck Surgery, 2nd edn. Oxford: Bios Scientific.
14. Snow JB and Ballenger JJ (2002) Congenital anomalies of the lar- ynx. In: Ballenger’s Otorhinolaryngology Head and Neck Sur- gery, 16th edn., pp. 1048–1072. New York: Decker.
15. Sulica L and Myssiorek D (2004) Vocal fold paralysis. Otolaryngologic Clinics of North America 37(1): 121–138.
Statistics
27 Views | 20 Downloads
How to Cite
K, V. S., K, S., JK, V. singh, P, N. S., Y, R., & Y, P. C. (2024). A review on upper respiratory tract infection. Asian Journal of Hospital Pharmacy, 4(4), 8-12. https://doi.org/10.38022/ajhp.v4i4.93
Section
Review Articles